China Meiyan Health: Shenzhen Stock Exchange agrees to resume reviewing this transaction.

Notice from Meinian Health: The company plans to purchase equity of multiple companies by issuing shares. On February 26, 2026, the company completed the update of financial information recorded in the application documents for this transaction and submitted a resumption review application to the Shenzhen Stock Exchange. On February 27, 2026, the Shenzhen Stock Exchange agreed to resume the review of this transaction. This transaction still needs to be approved by the Shenzhen Stock Exchange and registered by the China Securities Regulatory Commission before it can be implemented.